Cerity Partners LLC increased its position in Maximus, Inc. (NYSE:MMS - Free Report) by 3.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 123,273 shares of the health services provider's stock after acquiring an additional 4,006 shares during the quarter. Cerity Partners LLC owned about 0.22% of Maximus worth $8,406,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Norges Bank bought a new stake in Maximus in the 4th quarter valued at $71,443,000. SG Capital Management LLC bought a new stake in Maximus in the 4th quarter valued at $30,285,000. Federated Hermes Inc. boosted its holdings in Maximus by 74.8% in the 4th quarter. Federated Hermes Inc. now owns 882,953 shares of the health services provider's stock valued at $65,912,000 after purchasing an additional 377,705 shares during the period. Reinhart Partners LLC. boosted its holdings in Maximus by 65.4% in the 1st quarter. Reinhart Partners LLC. now owns 911,511 shares of the health services provider's stock valued at $62,156,000 after purchasing an additional 360,365 shares during the period. Finally, Squarepoint Ops LLC bought a new stake in Maximus in the 4th quarter valued at $22,661,000. Institutional investors own 97.21% of the company's stock.
Maximus Stock Performance
Maximus stock traded down $0.09 on Friday, hitting $71.25. The company's stock had a trading volume of 31,049 shares, compared to its average volume of 571,407. The firm has a market cap of $4.01 billion, a P/E ratio of 14.19 and a beta of 0.61. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.87. The company has a fifty day moving average price of $71.83 and a 200-day moving average price of $70.88. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.97.
Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.64. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.56% and a return on equity of 23.37%. The business's revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.57 EPS. On average, equities analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.
Maximus Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.68%. Maximus's payout ratio is currently 23.86%.
Insider Buying and Selling at Maximus
In other news, Director Gayathri Rajan sold 7,913 shares of the business's stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the transaction, the director directly owned 14,205 shares in the company, valued at approximately $1,028,157.90. The trade was a 35.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.60% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Separately, Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.
View Our Latest Report on Maximus
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.